1. Home
  2. LAW vs ENTA Comparison

LAW vs ENTA Comparison

Compare LAW & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$3.76

Market Cap

259.6M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.77

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
ENTA
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.6M
374.6M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
LAW
ENTA
Price
$3.76
$14.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$8.00
$20.40
AVG Volume (30 Days)
183.4K
114.8K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
22.58
29.93
EPS
N/A
N/A
Revenue
$156,849,000.00
$102,814,000.00
Revenue This Year
$11.23
$7.76
Revenue Next Year
$10.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.29
16.48
52 Week Low
$2.45
$4.73
52 Week High
$9.11
$17.15

Technical Indicators

Market Signals
Indicator
LAW
ENTA
Relative Strength Index (RSI) 45.45 66.38
Support Level $2.45 $13.39
Resistance Level $4.69 $15.52
Average True Range (ATR) 0.24 0.82
MACD 0.00 0.25
Stochastic Oscillator 59.48 94.87

Price Performance

Historical Comparison
LAW
ENTA

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: